Skip to main content

Stock futures surge as Johnson & Johnson coronavirus vaccine wins approval

Stock futures rallied Monday morning as investors celebrated approval of a third COVID-19 vaccine and as the U.S. House of Representatives passed a $1.9 trillion relief package.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.